abstract |
The present application relates to novel pharmaceutical dosage forms containing potent and selective inhibitors of TASK-1 and / or TASK-3 channels and sleep-related respiratory disorders such as obstructive and central sleep apnea and snoring And its use for treating and / or preventing respiratory disorders. |